Statistics from Altmetric.com
Cervical muscle weakness in amyotrophic lateral sclerosis (ALS) indicates a poor prognosis.1 Cervical weakness has several implications, not only disturbing posture and gait, but also affecting speaking and swallowing leading to drooling, reducing respiratory and cough efficacy and impairing social interactions. Cervical orthotics can improve some of these problems.2
Cervical muscles are important accessory muscles of respiration.3 The sternocleidomastoid is usually only recruited during greater respiratory efforts in healthy individuals, but is activated to support resting ventilation when the diaphragm is weak.3 Cervical extensor and other axial muscles can contribute to ventilation in ALS, when the diaphragm is weak.3 We have studied the association of cervical muscle strength and respiratory function in ALS.
We included consecutive ALS patients followed in our ALS clinic in Lisbon (2010–2017). Clinical assessment of flexor and extensor cervical strength was performed by one evaluator (MdC), using a standard clinical method. We recorded the revised functional ALS rating scale (ALSFRS-R) on the same day. Phrenic nerve studies and forced vital capacity (FVC) were performed within 3 months. Inclusion criteria were: definite, probable and probable laboratory-supported disease (revised El Escorial-criteria); evaluation of neck strength; disease progression. Exclusion criteria included: incomplete data; signs of dementia; severe respiratory symptoms; inability to tolerate the recumbent position; neck pain during cervical testing; associated neurological disorders; refusal of consent.
Cervical muscle strength
Strength of neck …
Contributors All authors have contributed to study planning; SP and MdC have done the clinical evaluations; SP and MG have inserted the clinical data in the database; SP has done the statistical analyses; SP, MdC and MS have contributed to the discussion and article review.
Funding This work was partially funded by the project: Comprehensive evaluation of circulating MicroRNA as diagnostic and prognostic biomarkers in Amyotrophic Lateral Sclerosis (PTDC/MEC-NEU/31195/2017).
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.